Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

NCT01859143 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Healthy

Interventions

BIOLOGICAL: Trivalent Influenza Vaccine
OTHER: Placebo

Sponsor

MedImmune LLC

Collaborators

[object Object]